AGTC
Applied Genetics Technologies Corporation (AGTC) is developing therapies designed to transform the lives of patients with severe diseases, offering hope to patients with unmet medical needs. With a highly specialized team of physicians and researchers, They use cutting-edge techniques to develop treatments for patients that have diseases caused by broken genes. They use gene therapy, which replaces those broken genes with normal functional genes, allowing a patient’s own body to produce proteins to treat their illness. A single injection provides long-lasting treatment, leading to a better quality of life for patients worldwide.
AGTC
Industry:
Biotechnology Clinical Trials Genetics Health Care Pharmaceutical
Founded:
1999-01-01
Address:
Alachua, Florida, United States
Country:
United States
Website Url:
http://www.agtc.com
Total Employee:
101+
Status:
Active
Contact:
+1 386-462-2204
Email Addresses:
[email protected]
Total Funding:
195.05 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Cloudflare Hosting Person Schema Gravatar Profiles Cloudflare DNS Microsoft COVID-19
Similar Organizations
4D Molecular Therapeutics
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
MedImmune Ventures
MedImmune Ventures investment in Series B - AGTC
Alta Partners
Alta Partners investment in Series B - AGTC
InterWest Partners
InterWest Partners investment in Series B - AGTC
SR One
SR One investment in Series B - AGTC
Intersouth Partners
Intersouth Partners investment in Series B - AGTC
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - AGTC
MedImmune Ventures
MedImmune Ventures investment in Venture Round - AGTC
InterWest Partners
InterWest Partners investment in Venture Round - AGTC
Intersouth Partners
Intersouth Partners investment in Venture Round - AGTC
Intersouth Partners
Intersouth Partners investment in Venture Round - AGTC
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2001-03-29 | Nanostream Inc. | AGTC investment in Series B - Nanostream Inc. | N/A |
Official Site Inspections
http://www.agtc.com
- Host name: 104.21.72.240
- IP address: 104.21.72.240
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AGTC"
Applied Genetic Technologies Corporation - Wikipedia
The Applied Genetic Technologies Corporation is a publicly traded biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has its headquarters in Alachua, Florida. In late June 2019, the company announced the appointment of Global Clinical and Medical Affairs Veteran, Theresa G.H. Heah, M.D., M.B.A., to Join as Chief Medical Officer. See details»
AGTC - Crunchbase Company Profile & Funding
Applied Genetics Technologies Corporation (AGTC) is developing therapies designed to transform the lives of patients with severe diseases, offering hope to patients with unmet medical needs. With a highly specialized team of …See details»
AGTC - LinkedIn
AGTC is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform the lives of patients with severe diseases, with an …See details»
Syncona Commences Tender Offer for All Outstanding Shares of …
Oct 26, 2022 Applied Genetic Technologies Corporation (Nasdaq: AGTC) (“AGTC” or the “Company”) and a newly established portfolio company of Syncona Limited (“Syncona”), a …See details»
agtc - Overview, News & Similar companies | ZoomInfo.com
Nov 28, 2022 agtc contact info: Phone number: (386) 462-2204 Website: www.agtc.com What does agtc do? Applied Genetic Technologies (agtc), founded in 1999 and headquartered in …See details»
Syncona to Acquire Applied Genetic Technologies Corporation
Oct 24, 2022 Upfront consideration in cash of $0.34 per share representing a premium of approximately 42% over AGTC’s closing stock price on October 21, 2022 Total consideration …See details»
Syncona to acquire struggling AGTC for $23.5 million
4 days ago AGTC-501 is currently in late-stage clinical development after completing a phase 2 follow-on study demonstrating significant visual sensitivity improvements and a favourable …See details»
Applied Genetic Technologies Corporation Reminds Shareholders …
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, …See details»
AGTC Exceeds Enrollment Target in SKYLINE Trial of …
Jan 11, 2022 Earlier this year, AGTC released updated data from the ongoing Phase1/2 clinical trial of AGTC-501, which demonstrated that at 12 months, 50% of patients in the high dose groups were considered ...See details»
Syncona to acquire Applied Genetic Technologies Corporation …
Oct 24, 2022 A newly established portfolio company of Syncona Limited will commence a tender offer to acquire all outstanding shares of AGTC for $0.34 per share, valuing AGTC at …See details»
Syncona Limited Portfolio Company Successfully Completes …
Dec 1, 2022 AGTC is advancing multiple pipeline candidates to address substantial unmet clinical needs in optogenetics, otology and CNS disorders, and has entered into strategic …See details»
AGTC Announces Expansion of Manufacturing and Analytics
May 13, 2021 AGTC is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system (CNS) …See details»
AGTC Presents Data from Ongoing Phase 1/2 Trial of AGTC-501 at …
Nov 12, 2021 AGTC Presents Data from Ongoing Phase 1/2 Trial of AGTC-501 at Upcoming American Academy of Ophthalmology 2021 Annual Meeting Applied Genetic Technologies …See details»
AgTC and AgETL: open-source tools to enhance data collection …
Feb 21, 2024 AgTC and AgETL can support plant science research from data collection to analysis. (A) Elements in the white background represent a typical series of steps taken in field …See details»
AGTC Advances in AAV Gene Therapy Manufacturing to be
May 4, 2021 AGTC is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system (CNS) …See details»
AGTC Announces Expansion of Manufacturing and Analytics …
AGTC is a leader in designing and constructing all critical gene therapy elements and bringing them together to develop customized therapies that address real patient needs.See details»
Working at Applied Genetics Technologies Corporation - Zippia
Mar 14, 2024 Applied Genetics Technologies Corporation (AGTC) is developing therapies designed to transform the lives of patients with severe diseases, offering hope to patients with …See details»
The first steps in gene therapy for achromatopsia
May 14, 2021 Reviewed by Mark E. Pennesi, MD, PhD. The preliminary results of 2 ongoing phase 1/2 clinical trials evaluating the effects of subretinal gene therapies for achromatopsia …See details»
AGTC Hosts Topping Off Ceremony for Gene Therapy …
May 10, 2022 About AGTC AGTC is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system …See details»
*FINAL REMINDER* AGTC Urges Shareholders to Tender Their …
Nov 28, 2022 A Syncona Limited portfolio company has commenced a tender offer to purchase all outstanding shares of AGTC common stock at a price per share of $0.34 in cash plus the …See details»